Zheng Wu

CA 19-9 tumor marker: is it reliable? A case report in a patient with pancreatic cancer.

R. Wadleigh, Zheng Wu, A. Kuntz, 2013, Clinical advances in hematology & oncology : H&O.

Circulating microRNA profile predicts disease progression in patients receiving second-line treatment of lapatinib and capecitabine for metastatic pancreatic cancer

J. Marshall, A. Wellstein, L. Weiner, 2016, Oncology letters.

Preoperative evaluation and treatment of rectal cancer

J. Marshall, Zheng Wu, 2010 .

Reducing nihilism in metastatic pancreatic ductal adenocarcinoma: Treatment, sequencing, and effects on survival outcomes

Kenneth H. Yu, E. O’Reilly, A. Surinach, 2020, Cancer medicine.

Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer

J. Marshall, L. Weiner, M. Pishvaian, 2015, Cancer Chemotherapy and Pharmacology.